📣 VC round data is live. Check it out!
- Public Comps
- Kneat
Kneat Valuation Multiples
Discover revenue and EBITDA valuation multiples for Kneat and similar public comparables like Medical Data Vision, Beijing Sunwayworld, Medley Inc., Vitalhub and more.
Kneat Overview
About Kneat
kneat.com Inc is in the business of developing and marketing a software application for modeling regulated data-intensive processes for regulated industries, focusing on the life sciences industry. The company has developed the Kneat Gx solution which provides management real-time visibility and control and increases product, quality, and compliance. In addition, it provides software-related services including training, installation, upgrades, consulting and maintenance, which include product support services. The company geographically operates in North America, Europe and Asia Pacific, out of which it earns maximum revenue from North America.
Founded
2013
HQ

Employees
297
Website
Financials (LTM)
EV
$363M
Valuation Multiples
Start free trialKneat Financials
Kneat reported last 12-month revenue of $51M and EBITDA of $8M.
In the same LTM period, Kneat generated $39M in gross profit, $8M in EBITDA, and had net loss of ($3M).
Revenue (LTM)
Kneat P&L
In the most recent fiscal year, Kneat reported revenue of $46M and EBITDA of $11M.
Kneat is unprofitable as of last fiscal year, with gross margin of 75%, EBITDA margin of 24%, and net margin of (4%).
Financial data powered by Morningstar, Inc.
Kneat Stock Performance
Kneat has current market cap of $381M, and enterprise value of $363M.
Market Cap Evolution
Kneat's stock price is $3.97.
Kneat share price increased by 1.0% in the last 30 days, and decreased by 9.8% in the last year.
Kneat has an EPS (earnings per share) of $-0.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $363M | $381M | 0.4% | 1.0% | 56.1% | -9.8% | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialKneat Valuation Multiples
Kneat trades at 7.2x EV/Revenue multiple, and 43.0x EV/EBITDA.
EV / Revenue (LTM)
Kneat Financial Valuation Multiples
As of June 3, 2026, Kneat has market cap of $381M and EV of $363M.
Kneat has a P/E ratio of (111.6x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Kneat Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Kneat Margins & Growth Rates
Kneat grew revenue by 22% but EBITDA decreased by 3% in the last fiscal year.
In the most recent fiscal year, Kneat reported gross margin of 75%, EBITDA margin of 24%, and net margin of (4%).
Kneat Margins
Kneat Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Kneat Operational KPIs
Kneat's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Kneat's Rule of 40 is 43% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Kneat's Rule of X is 78% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Kneat Competitors
Kneat competitors include Medical Data Vision, Beijing Sunwayworld, Medley Inc., Vitalhub, Simulations Plus, Software Service, Weave Communications, Ascom, Claritev and Optima Health.
Most Kneat public comparables operate across Healthcare Software, B2B SaaS, HealthTech and Vertical SaaS.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | 9.2x | - | - | |||
| 6.5x | - | 112.1x | - | |||
| 1.9x | 1.7x | 14.5x | 13.4x | |||
| 3.2x | 3.0x | 13.2x | 11.7x | |||
| 3.8x | 3.7x | 13.5x | 13.2x | |||
| 0.8x | 0.8x | 3.6x | 4.9x | |||
| 1.9x | 1.8x | 58.8x | 39.0x | |||
| 0.7x | 0.7x | 5.9x | 6.0x | |||
This data is available for Pro users. Sign up to see all Kneat competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Kneat
| When was Kneat founded? | Kneat was founded in 2013. |
| Where is Kneat headquartered? | Kneat is headquartered in Ireland. |
| How many employees does Kneat have? | As of today, Kneat has over 297 employees. |
| Who is the CEO of Kneat? | Kneat's CEO is Edmund Ryan. |
| Is Kneat publicly listed? | Yes, Kneat is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Kneat? | Kneat trades under KSI ticker. |
| When did Kneat go public? | Kneat went public in 2014. |
| Who are competitors of Kneat? | Kneat main competitors include Medical Data Vision, Beijing Sunwayworld, Medley Inc., Vitalhub, Simulations Plus, Software Service, Weave Communications, Ascom, Claritev, Optima Health. |
| What is the current market cap of Kneat? | Kneat's current market cap is $381M. |
| What is the current revenue of Kneat? | Kneat's last 12 months revenue is $51M. |
| What is the current revenue growth of Kneat? | Kneat revenue growth (NTM/LTM) is 23%. |
| What is the current EV/Revenue multiple of Kneat? | Current revenue multiple of Kneat is 7.2x. |
| What is the current EBITDA of Kneat? | Kneat's last 12 months EBITDA is $8M. |
| What is Kneat's EBITDA margin? | Kneat's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Kneat? | Current EBITDA multiple of Kneat is 43.0x. |
| What is the current FCF of Kneat? | Kneat's last 12 months FCF is ($6M). |
| What is Kneat's FCF margin? | Kneat's last 12 months FCF margin is (12%). |
| What is the current EV/FCF multiple of Kneat? | Current FCF multiple of Kneat is (58.6x). |
| How many companies Kneat has acquired to date? | Kneat hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Kneat has invested to date? | Kneat hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Kneat
Lists including Kneat
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.